title: Defining the appropriate starting dose of lenalidomide in chronic lymphocytic leukemia: remember the old fable of the hare and the tortoise.
authors.affiliation: a Department of Haematology , Peter MacCallum Cancer Centre , Melbourne , Victoria , Australia ;|b Department of Medicine, University of Melbourne , Melbourne , Victoria , Australia ;
authors.forename: Constantine S
authors.initials: CS
authors.lastname: Tam
authors.affiliation: c Department of Hematology , Hadassah University Hospital and Hebrew University Medical School , Jerusalem , Israel.
authors.forename: Aaron
authors.initials: A
authors.lastname: Polliack
mesh_terms: D000818:Animals; D000970:Antineoplastic Agents / Q000627:therapeutic use; D034621:Hares; D006801:Humans; D015451:Leukemia, Lymphocytic, Chronic, B-Cell / Q000188:drug therapy*
chemical_list: D000970:Antineoplastic Agents